GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Aurora Spine Corp (TSXV:ASG) » Definitions » Capital Expenditure

Aurora Spine (TSXV:ASG) Capital Expenditure : C$-0.87 Mil (TTM As of Mar. 2025)


View and export this data going back to 2013. Start your Free Trial

What is Aurora Spine Capital Expenditure?

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Aurora Spine's cash flow for capital expenditures for the three months ended in Mar. 2025 was C$-0.28 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Mar. 2025 was C$-0.87 Mil.


Aurora Spine Capital Expenditure Historical Data

The historical data trend for Aurora Spine's Capital Expenditure can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aurora Spine Capital Expenditure Chart

Aurora Spine Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Capital Expenditure
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.71 -0.92 -1.19 -0.64 -0.91

Aurora Spine Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Capital Expenditure Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.29 -0.20 -0.09 -0.30 -0.28

Aurora Spine Capital Expenditure Calculation

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Capital Expenditure for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.87 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Aurora Spine Business Description

Traded in Other Exchanges
Address
20 Holly Street, Suite 300, Toronto, ON, CAN, M4S 3B1
Aurora Spine Corp is engaged in the development, manufacture, and selling of minimally invasive, interspinous fusion systems and devices. These 510K and patent protected medical devices improve patient outcomes in the area of spine and sacroiliac joint surgical procedures. The company is focused on bringing new solutions to the spinal implant market through a series of minimally invasive, regenerative spinal implant technologies.
Executives
James Snow Director
Trent James Northcutt 10% Security Holder, Director, Senior Officer
Chad Clouse Senior Officer
Laszlo Garamszegi Senior Officer
David Aubrey Rosenkrantz Director